THE ROLE OF MICRONIZED PROGESTERONE IN THE PREVENTION OF PRETERM BIRTH IN WOMEN WITH CERVICAL LENGTH GREATER THAN 2.5 CM

T AKHTAR; T REHMAN; A MANSOOR

doi:10.54112/bcsrj.v2023i1.648

Authors

T AKHTAR Department of Gynaecology, Gujranwala Medical College, Pakistan
T REHMAN Department of Gynaecology, Allied Hospital Faisalabad, Pakistan
A MANSOOR Department of Gynaecology, Gujranwala Medical College, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.648

Keywords:

Preterm Birth Prevention, Micronized Progesterone, Cervical Length, Singleton Gestation, Prospective Study, Pregnancy, Adverse Neonatal Outcomes

Abstract

Preterm birth, defined as the delivery of a baby before 37 weeks of gestation, remains a significant public health concern globally due to its association with adverse neonatal outcomes and long-term health implications. The study's main objective is to find the role of Micronized progesterone in preventing preterm birth in women with cervical length greater than 2.5 cm. This prospective study was conducted in DHQ Teaching Hospital Gujranwala in 2023. Data was collected from 120 female patients. The study population comprises pregnant women with a singleton gestation, cervical length greater than 2.5 cm, and no history of preterm birth. Informed consent is obtained from all participants, and ethical approval is secured from relevant institutional review boards. Micronized progesterone demonstrated a 5% preterm birth rate compared to 10% in the control group (p=0.03). Adherence was high (92%), and adverse events were mild. Birth weight increased in the intervention group. Subgroup analysis revealed consistent preventive effects across various cervical length strata. It is concluded that micronized progesterone supplementation among women with cervical length > 2.5 cm shows promise in reducing preterm birth rates. The safety profile and adherence support its feasibility in routine prenatal care.

Downloads

Download data is not yet available.

References

Afridi, N., Masood, U., Balooch, S., Khan, S., and Khan, S. (2019). Comparison of efficacy of oral progesterone and micronized progesterone pessary in reduction of incidence of spontaneous preterm births. Journal of Ayub Medical College Abbottabad 31, 248-251.

Alsulmi, E. S., Alfaraj, M., Faden, Y., and Al Qahtani, N. (2020). The use of progesterone during pregnancy to prevent preterm birth. Saudi Medical Journal 41, 333.

Ashoush, S., El‐Kady, O., Al‐Hawwary, G., and Othman, A. (2017). The value of oral micronized progesterone in the prevention of recurrent spontaneous preterm birth: a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica 96, 1460-1466.

Catov, J. M., Scifres, C. M., Caritis, S. N., Bertolet, M., Larkin, J., and Parks, W. T. (2017). Neonatal outcomes following preterm birth classified according to placental features. American journal of obstetrics and gynecology 216, 411. e1-411. e14.

Conde-Agudelo, A., and Romero, R. (2022). Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 227, 440-461. e2.

Conde-Agudelo, A., Romero, R., Rehal, A., Brizot, M. L., Serra, V., Da Fonseca, E., Cetingoz, E., Syngelaki, A., Perales, A., and Hassan, S. S. (2023). Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology.

Crump, C., Sundquist, J., and Sundquist, K. (2020). Risk of hypertension into adulthood in persons born prematurely: a national cohort study. European Heart Journal 41, 1542-1550.

de Gamarra-Oca, L. F., Ojeda, N., Gómez-Gastiasoro, A., Peña, J., Ibarretxe-Bilbao, N., García-Guerrero, M. A., Loureiro, B., and Zubiaurre-Elorza, L. (2021). Long-term neurodevelopmental outcomes after moderate and late preterm birth: a systematic review. The Journal of Pediatrics 237, 168-176. e11.

Esplin, M. S., Manuck, T. A., Varner, M. W., Christensen, B., Biggio, J., Bukowski, R., Parry, S., Zhang, H., Huang, H., and Andrews, W. (2015). Cluster analysis of spontaneous preterm birth phenotypes identifies potential associations among preterm birth mechanisms. American journal of obstetrics and gynecology 213, 429. e1-429. e9.

Fahmy, M. A., Ahmed, A., and Marai, A. A. E.-F. (2021). Vaginal Progesterone versus Cervical Cerclage to Prevent Preterm Birth. Al-Azhar International Medical Journal 2, 59-63.

Iqbal, S., Hanif, S., Nisa, Z. U., Shabbir, A., Anwar, K., and Afridi, N. (2023). Comparison of the Effectiveness of Oral Progesterone and Micronized Progesterone Pessary in Reducing the Spontaneous Preterm Birth Incidences. Pakistan Journal of Medical & Health Sciences 17, 395-395.

Khandelwal, M. (2012). Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy. International journal of women's health, 481-490.

Partlett, C., and Riley, R. D. (2017). Random effects meta‐analysis: coverage performance of 95% confidence and prediction intervals following REML estimation. Statistics in medicine 36, 301-317.

Perin, J., Mulick, A., Yeung, D., Villavicencio, F., Lopez, G., Strong, K. L., Prieto-Merino, D., Cousens, S., Black, R. E., and Liu, L. (2022). Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals. The Lancet Child & Adolescent Health 6, 106-115.

Phillips, C., Velji, Z., Hanly, C., and Metcalfe, A. (2017). Risk of recurrent spontaneous preterm birth: a systematic review and meta-analysis. BMJ open 7.

Rehal, A., Benkő, Z., Matallana, C. D. P., Syngelaki, A., Janga, D., Cicero, S., Akolekar, R., Singh, M., Chaveeva, P., and Burgos, J. (2021). Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial. American Journal of Obstetrics and Gynecology 224, 86. e1-86. e19.

Rocha, A. S., de Cássia Ribeiro‐Silva, R., Paixao, E. S., Falcão, I. R., Alves, F. J. O., Ortelan, N., de Almeida, M. F., Fiaccone, R. L., Rodrigues, L. C., and Ichihara, M. Y. (2022). Recurrence of preterm births: A population‐based linkage with 3.5 million live births from the CIDACS Birth Cohort. International Journal of Gynecology & Obstetrics 158, 605-612.

Romero, R., Espinoza, J., Kusanovic, J. P., Gotsch, F., Hassan, S., Erez, O., Chaiworapongsa, T., and Mazor, M. (2006). The preterm parturition syndrome. BJOG: An International Journal of Obstetrics & Gynaecology 113, 17-42.

Schünemann, H. J., Vist, G. E., Higgins, J. P., Santesso, N., Deeks, J. J., Glasziou, P., Akl, E. A., Guyatt, G. H., and Group, C. G. M. (2019). Interpreting results and drawing conclusions. Cochrane handbook for systematic reviews of interventions, 403-431.

Srisutham, K., Wuttikonsammakit, P., and Chamnan, P. (2021). Efficacy of Vaginal and Oral Progesterone After Tocolytic Therapy in Threatened Preterm Labor: A 3-Arm Parallel-Group Randomized Controlled Trial. Journal of the Medical Association of Thailand 104.